ARTICLE | Company News
TiGenix autoimmune, gene/cell therapy news
January 2, 2012 8:00 AM UTC
The REGENER-AR consortium led by TiGenix received a €5.9 million ($7.7 million) grant from the European Commission's Framework Program 7 (FP7) to support development of TiGenix's Cx611 to treat rheum...